廈門鎢業(600549.SH):下屬子公司擬投資3285萬元對可轉位刀具產品線進行瓶頸工序的擴產及自動化改造
格隆匯 12 月 28日丨廈門鎢業(600549.SH)公佈,公司召開第八屆董事會第三十三次會議,通過了《關於下屬子公司廈門金鷺特種合金有限公司可轉位刀具瓶頸工序擴產及自動化改造項目的議案》。
會議同意投資3285萬元對可轉位刀具(即“數控刀片”)產品線進行瓶頸工序的擴產及自動化改造,該項目有利於公司打造國產刀具高端品牌,符合公司未來經營發展需要。項目預計於2021年12月建成投產,建成後預計新增銷售收入約3382萬元/年,新增淨利潤約1,817萬元/年。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.